ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibroblasts, Synovial"

  • Abstract Number: 0051 • ACR Convergence 2022

    Identification of a Transcription Factor That Drives Polarization Toward Tissue-destructive Fibroblasts in Arthritis

    MINGLU YAN1, Noriko Komatsu1, Ryunosuke Muro1, Hiroyuki Takaba1, Takeshi Nitta1, Kazuo Okamoto1, Masayuki Tsukasaki2 and Hiroshi Takayanagi1, 1University of Tokyo, Tokyo, Japan, 2The Univerisity of Tokyo, Tokyo, Japan

    Background/Purpose: Fibroblasts exert important homeostatic functions but can also drive disease pathogenesis. In rheumatoid arthritis (RA), synovial fibroblasts (SFs) contribute to the joint destruction by…
  • Abstract Number: 0620 • ACR Convergence 2022

    Neovascularization Is Altered by Rheumatoid Arthritis Synovial Fibroblasts and Canstatin in Vitro and in Vivo

    Corinna Heck1, Daria Kürsammer1, Klaus Frommer2, Mona Arnold3, Stefan Rehart4, Ulf Müller-Ladner5 and Elena Neumann3, 1Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Bad Nauheim, Germany, 2Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, 3JLU Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 4Agaplesion Markus Hospital, Dpt of Orthopaedics and Trauma Surgery, Frankfurt, Germany, 5JLU Campus KK, Bad Nauheim, Germany

    Background/Purpose: In the pathogenesis of rheumatoid arthritis (RA), neovascularization is increased in the activated and inflamed synovium. RA synovial fibroblasts (RASF) are key players in…
  • Abstract Number: 0499 • ACR Convergence 2022

    Drivers of Heterogeneity in Synovial Fibroblasts in Rheumatoid Arthritis

    Melanie Smith1, Vianne Gao2, Edward DiCarlo1, Susan Goodman1, Thomas Norman2, Laura Donlin1, Christina Leslie2 and Alexander Rudensky2, 1Hospital for Special Surgery, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by hyperplasia of both the synovial lining, which forms the synovial fluid interface, as well as the synovial sublining,…
  • Abstract Number: 0623 • ACR Convergence 2022

    Rheumatoid Synovial Fibroblasts Display Imprinted Memory of Their Synovial Endotype Which Can Be Plastically Modulated by B-cells Crosstalk

    Edoardo Prediletto1, Cankut Cubuk2, Elena Pontarini3, Felice Rivellese2, Alessandra Nerviani2, Davide Lucchesi3, Mattia Caliste1, Elisa Corsiero1, Manzoor Ahmed3, rebecca hands3, Myles Lewis2, Costantino Pitzalis2 and Michele Bombardieri4, 1Wlliam Harvey Research Institute Queen Mary University on London, London, United Kingdom, 2Queen Mary University of London, London, United Kingdom, 3William Harvey Research Institute, London, United Kingdom, 4Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University, London, United Kingdom

    Background/Purpose: Despite advances in the treatment of Rheumatoid Arthritis (RA), synthetics and biologicals drugs are ineffective in ~40% of patients. The origin of this refractoriness…
  • Abstract Number: 0500 • ACR Convergence 2022

    T Cell and Macrophage Synergy Drive Inflammatory Synovial Fibroblasts in Rheumatoid but Not Psoriatic Arthritis

    Achilleas Floudas1, conor Smith2, Orla Tynan3, Nuno Neto4, Krishna Vinod5, Sarah Wade6, Megan Hanlon7, Clare Cunningham4, Viviana Marzaioli8, Mary Canavan9, Jean Fletcher3, Ronan Mullan10, Suzanne Cole11, Ling-Yang Hao12, Michael Monaghan4, Sunil Nagpal13, Douglas Veale14 and Ursula Fearon4, 1Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Ireland, 2bTrinity College Dublin, Dublin, Ireland, 3Trinity Biomedical Sciences Institute, Dublin, Ireland, 4Trinity College Dublin, Dublin, Ireland, 5Janssen, Spring House, PA, 6Trinity Biomedical Sciences Institute, Wexford, Ireland, 7Molecular Rheumatology, Dublin, Ireland, 8Trinity College Dublin and University College Dublin, Dublin, Ireland, 9Trinity College, Dublin, Ireland, 10Tallaght University Hospital, Dublin, Ireland, 11Rheumatic Disease Associates, Warminster, PA, 12Janssen Research and Development, LLC, Spring House, PA, 13Janssen Research, Collegeville, PA, 14St. Vincent's University Hospital, Blackrock, Dublin, Ireland

    Background/Purpose: Rheumatoid (RA) and psoriatic arthritis (PsA) are common autoimmune diseases of unknown aetiology characterised by complex synovial pathology with a detrimental effect on the…
  • Abstract Number: 0626 • ACR Convergence 2022

    Elucidating the Expression and Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Human Rheumatoid Arthritis Synovial Fibroblasts and a Rat Adjuvant-induced Arthritis Model

    Meena Afroze Shanta1, Farheen Sultan Shaikh2, Bhanupriya Madarampalli3 and Salahuddin Ahmed2, 1College of Pharmacy and Pharmaceutical Science, Washington State University, Spokane, WA, 2Washington State University, Spokane, WA, 3University of Washington, Bellevue, WA

    Background/Purpose: Proprotein convertase subtilisin/Kexin type-9 (PCSK9) is the most recognized serine protease for its pathological role in cardiovascular diseases, however, its role in inflammatory diseases,…
  • Abstract Number: 0558 • ACR Convergence 2022

    Molecular Interplay Between Mammalian Target of Rapamycin (mTOR) and the YAP Pathway Mediates Rheumatoid Arthritis Synovial Fibroblast Activation

    Brianne Barker1, Megan Hanlon2, Siobhan Wade1, Douglas Veale3, Ursula Fearon1 and Mary Canavan4, 1Trinity College Dublin, Dublin, Ireland, 2Molecular Rheumatology, Dublin, Ireland, 3St. Vincent's University Hospital, Blackrock, Dublin, Ireland, 4Trinity College, Dublin, Ireland

    Background/Purpose: mTOR is a metabolic master regulator of both innate and adaptive immunity, however its exact role in synovial fibroblasts is unknown. RA synovial fibroblasts…
  • Abstract Number: 0627 • ACR Convergence 2022

    Spatial Transcriptomic Analysis Reveals Vascular Zonation of Myofibroblasts in Rheumatoid Arthritis Synovium

    Kartik Bhamidipati1, Roopa Madhu1, Sonia Presti1, Youngmi Kim2, Ye Cui2, Fan Zhang3, Anna Jonsson1, Aparna Nathan1, Nghia Millard1, Deepak Rao1, Laura Donlin4, Jennifer Anolik5, Soumya Raychaudhuri1, Michael Brenner6, Ilya Korsunsky1 and Kevin Wei7, 1Brigham and Women's Hospital, Boston, MA, 2Nanostring Technologies Inc., Seattle, WA, 3University of Colorado, Aurora, CO, 4Hospital for Special Surgery, New York, NY, 5University of Rochester Medical Center, Rochester, NY, 6Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Many rheumatoid arthritis (RA) patients do not achieve sustained remission despite multiple lines of therapy. Recent studies have linked the expansion of synovial fibroblasts…
  • Abstract Number: 0578 • ACR Convergence 2022

    Interleukin-6 Trans-Signaling Induces Synovial Fibroblast Invasiveness by Utilizing Ets2 Protein

    Anil Singh, Paul Panipinto, Farheen Sultan Shaikh and Salahuddin Ahmed, Washington State university, Spokane, WA

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease with a complex interplay of synovial cells and soluble factors that create the signatures of chronic inflammation…
  • Abstract Number: 1094 • ACR Convergence 2022

    Mechanical Loading-induced BHLHE40 Promotes Inflammatory Arthritis

    Eric Gracey1, Carolien Vlieghe2, Isabelle Cambre1, Elisabeth Gilis1, Flore Stappers3, Guillaume Planckaert1, Rik Lories4, Aline Bozec5 and Dirk Elewaut6, 1Ghent University, Gent, Belgium, 2VIB-UGent Center for Inflammation Research, Ghent University, Belgium, Gent, Belgium, 3VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium, 4KU Leuven, Leuven, Belgium, 5Universitätsklinikum Erlangen, Erlangen, Germany, 6Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium

    Background/Purpose: Force induced microdamage to joint tissue is hypothesized to trigger inflammatory events in the joint leading to arthritis. Patients with inflammatory arthritis, such as…
  • Abstract Number: 0515 • ACR Convergence 2021

    The Extracellular Sulfatase-2 Inhibitor OKN-007 Abrogates TNF-α-induced Inflammatory Mediators in Human Rheumatoid Arthritis Synovial Fibroblasts

    Ruby Siegel, Sang Han and Salah-uddin Ahmed, Washington State University, Spokane, WA

    Background/Purpose: Recent unpublished findings from our lab show that the extracellular enzyme sulfatase-2 (Sulf-2) facilitates pro-inflammatory TNF-α signaling which activates rheumatoid arthritis synovial fibroblasts (RASFs).…
  • Abstract Number: 0527 • ACR Convergence 2021

    Role of Terminal Uridylyl Transferase 7 in TNF-α-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts In Vitro

    Anil singh, farheen Shaikh and Salah-uddin Ahmed, Washington State University, Spokane, WA

    Background/Purpose: Terminal uridylyl transferase 7 (TUT7), also known as Zcchc6, is a zinc finger domain-containing protein responsible for terminal uridylation of miRNA, implicated in pre-miRNA…
  • Abstract Number: 0940 • ACR Convergence 2021

    Overactivation of the Kinase IKK2 Causes a Hand Osteoarthritis-Like Phenotype in Mice

    Sergio Ramirez-Perez, kyle Jones, Umesh Gangishetti and Pallavi Bhattaram, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Hand osteoarthritis (OA) presents the highest prevalence among rheumatic diseases. Synovitis is a defining feature in hand OA that has been associated with radiographic…
  • Abstract Number: 1003 • ACR Convergence 2021

    Significant Enrichment of Pathogenic CD206+CD163+ Macrophages in Rheumatoid Arthritis Synovial Tissue with Distinct Transcriptional Signatures

    Megan Hanlon1, Mary Canavan2, Nuno Neto3, Qingxuan Song4, Phil Gallagher5, Ronan Mullan6, Conor Hurson7, Barry Moran3, Michael Monaghan3, Sunil Nagpal8, Douglas Veale9 and Ursula Fearon3, 1Molecular Rheumatology, Dublin, Ireland, 2Trinity College, Santry, Ireland, 3Trinity College Dublin, Dublin, Ireland, 4Janssen Research & Development LLC, Spring House, PA, 5St Vincent's Hospital, Dublin, Ireland, 6Tallaght University Hospital, Dublin, Ireland, 7St Vincents University Hospital, Dublin, Ireland, 8Janssen Research, Collegeville, PA, 9University College Dublin, Dublin, Ireland

    Background/Purpose: Synovial tissue macrophages are an exquisitely plastic pool of innate cells that play a key role in RA disease progression. However, the precise nature,…
  • Abstract Number: 0011 • ACR Convergence 2021

    Differential Inflammation-mediated Function of Prokineticin 2 in the Synovial Fibroblasts of Patients with Rheumatoid Arthritis Compared to Osteoarthritis

    Kentaro Noda, Bianca Dufner and Rainer Straub, Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany

    Background/Purpose: Prokineticin 2 (PK2) is a secreted protein involved in several pathological and physiological processes, including the regulation of inflammation, sickness behaviors, and the circadian…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology